Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Friedreich Ataxia 1”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Early research (Phase 1)Not Yet RecruitingNCT06772870
What this trial is testing

A Single Ascending Dose Study of DT-216P2 in Normal Healthy Participants

Who this might be right for
Friedreich Ataxia
Design Therapeutics, Inc. 36
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Early research (Phase 1)Looking for participantsNCT06054893
What this trial is testing

Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old

Who this might be right for
Friedreich Ataxia
Biogen 35
Not applicableStudy completedNCT03120013
What this trial is testing

Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia

Who this might be right for
Ataxia, CerebellarCerebellar AtaxiaSpinocerebellar Ataxias+8 more
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 21
Early research (Phase 1)Ended earlyNCT06681766
What this trial is testing

Assess Nomlabofusp in Adolescents and Children With Friedreich's Ataxia

Who this might be right for
Friedreich Ataxia
Larimar Therapeutics, Inc. 18
Early research (Phase 1)Study completedNCT00078481
What this trial is testing

Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia

Who this might be right for
Friedreich Ataxia
National Institute of Neurological Disorders and Stroke (NINDS) 16
Early research (Phase 1)Study completedNCT04519567
What this trial is testing

Multiple Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia

Who this might be right for
Friedreich Ataxia
Larimar Therapeutics, Inc. 27
Testing effectiveness (Phase 2)Looking for participantsNCT06874010
What this trial is testing

A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia

Who this might be right for
Friedreich Ataxia
Design Therapeutics, Inc. 20
Not applicableStudy completedNCT04268147
What this trial is testing

Instrumented Data Exchange for Ataxia Study

Who this might be right for
Spinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 2Spinocerebellar Ataxia Type 3+2 more
University of Chicago 128
Testing effectiveness (Phase 2)Active Not RecruitingNCT05445323
What this trial is testing

Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia

Who this might be right for
Friedreich AtaxiaCardiomyopathy, Secondary
Lexeo Therapeutics 8
Early research (Phase 1)Study completedNCT01898884
What this trial is testing

Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia

Who this might be right for
Friedreich's Ataxia
Shire 46
Early research (Phase 1)Study completedNCT04176991
What this trial is testing

Single Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia

Who this might be right for
Friedreich Ataxia
Larimar Therapeutics, Inc. 28
Large-scale testing (Phase 3)Looking for participantsNCT06953583
What this trial is testing

Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old (BRAVE)

Who this might be right for
Friedreich Ataxia
Biogen 255
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Not applicableStudy completedNCT04192136
What this trial is testing

NAD+ and Exercise in FA

Who this might be right for
Friedreich Ataxia 1
Children's Hospital of Philadelphia 75